Quick Answer
Cytek Biosciences, Inc. reported Total Revenue of $201.49 million for fiscal year 2025.
Cytek Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $201.49M | +0.5% |
| 2024 | $200.45M | +3.9% |
| 2023 | $193.01M | +17.7% |
| 2022 | $164.04M | +28.2% |
| 2021 | $127.95M | +37.8% |
| 2020 | $92.84M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $52.29M | +1.5% | +14.7% |
| June 30, 2025 | $45.60M | -2.2% | +10.0% |
| March 31, 2025 | $41.46M | -7.6% | -19.5% |
| September 30, 2024 | $51.50M | +7.3% | +10.5% |
| June 30, 2024 | $46.62M | -6.2% | +3.9% |
| March 31, 2024 | $44.86M | +21.0% | -6.5% |
| September 30, 2023 | $48.00M | +18.6% | -3.4% |
| June 30, 2023 | $49.69M | +23.7% | +34.0% |
- Cytek Biosciences, Inc. showed an increase of +0.5% in Total Revenue compared to the prior fiscal year.
- Over the 2020–2025 period, Cytek Biosciences, Inc.’s total revenue has grown by 117.0% (from $92.84 million to $201.49 million).
- The most recent figure is from Cytek Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: